In: Septic Shock7 Nov 2014
Correlation of Ejection Fraction with Extent of Myocardial Cell Shortening
Figure 3 illustrates the relationship between the radionuclide determined in vivo EF (days 2 to 4) and the in vitro percentage of change in extent of myocardial cell shortening in the 14 septic shock patients with MDS. As mentioned above, a positive assay for MDS was defined as at least a 20 percent in vitro depression of the extent of myocardial cell shortening. The degree of in vitro depression ranged from 20 percent to 62 percent, with a mean of 35 percent. The EFs ranged from 7 percent to 52 percent, with a mean of 28 percent. Using Spearman rank coefficients, there was a significant correlation between these two variables (r= -0.60, p<0.05).
The results of ultrafiltration experiments on sera from critically ill nonseptic patients, septic patients with and without MDS activity, and normal human volunteers are summarized in Table 3. MDS activity did not pass through 10,000 or 30,000 dalton Amicon filters. No MDS activity was found in either the filtrate or the supernatant in critically ill nonseptic patients or in normal human volunteers. In patients positive for MDS, MDS activity was found only in supernatants containing molecules above 10,000 and 30,000 daltons. Serum with MDS activity maintained its activity despite multiple freezings at — 70°C and repetitive rapid thawings. there
This study extends our understanding of cardiovascular dysfunction and the role of a circulating MDS in the pathogenesis of human septic shock. In this study, the presence of circulating myocardial depressant activity was temporally associated with cardiovascular abnormalities—specifically, reversible myocardial depression and ventricular dilatation, changes that characterize human septic shock. When compared with MDS negative patients, septic shock patients achieving strict criteria for the presence of a circulating MDS had a statistically greater decrease in LVEF and a lower minimum EF.
Figure 3. The relationship between the radionuclide determined in vivo EF (days 2 to 4) and the maximum in vitro percent change in extent of myocardial cell shortening with serum from 14 septic shock patients with MDS.
Table 3—Results of ImrajUtration Experiments in Septic Shock Patients with and without MDS, Critically IU ‘Nonseptic Patients, and Normal Human Volunteers
|SubjectGroup||10,000 Daltons||30,000 Daltons|
|Critically ill, nonseptic||0/5||0/5||0/5||0/5|
Blog invites submissions of review articles, reports on clinical techniques, case reports, conference summaries, and articles of opinion pertinent to the control of pain and anxiety in dentistry.